A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

Jennifer R. Grandis, Mona F. Melhem, William E. Gooding et al. · JNCI Journal of the National Cancer Institute · 1998 · 1.1K citations · Full text

Medicine, Oncology, Pathology +17

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Denis Soulières, Neil Senzer, Everett E. Vokes et al. · Journal of Clinical Oncology · 2003 · 808 citations · Full text

Medicine, Oncology, Pharmacology +11

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

Neil I. Goldstein, Marie Prewett, Kazys Zuklys et al. · PubMed · 1995 · 790 citations

Medicine, Oncology, Pharmacology +14

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations

Medicine, Oncology, Pharmacotherapy +13